Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Effector mechanisms in demyelinating neuropathies

H P Hartung1, J Zielasek, S Jung

  • 1Department of Neurology, Julius-Maximilians-Universität, Würzburg, Germany.

Revue Neurologique
|May 1, 1996
PubMed
Summary

The exact causes of immune-mediated neuropathies are unknown, but research shows antibodies and macrophages damage myelin. Understanding these mechanisms may lead to better treatments for conditions like Guillain-Barr-e syndrome.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Joint crisis plans in mental health hospitals-Real practice in an association of psychiatric hospitals].

Der Nervenarzt·2022
Same author

Correction to: The current standing of autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis.

Journal of neurology·2022
Same author

The current standing of autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis.

Journal of neurology·2022
Same author

Identification of risk factors for involuntary psychiatric hospitalization: using environmental socioeconomic data and methods of machine learning to improve prediction.

BMC psychiatry·2020
Same author

EPA guidance on the quality of mental health services: A systematic meta-review and update of recommendations focusing on care coordination.

European psychiatry : the journal of the Association of European Psychiatrists·2020
Same author

Upscaling e-mental health in Europe: a six-country qualitative analysis and policy recommendations from the eMEN project.

European archives of psychiatry and clinical neuroscience·2020

Area of Science:

  • Neuroimmunology
  • Neuropathology

Background:

  • Immune-mediated neuropathies, including Guillain-Barr-e syndrome (GBS), CIDP, and paraproteinemic neuropathies, have unknown causes.
  • Significant progress has been made in understanding the mechanisms of myelin destruction in these conditions.

Purpose of the Study:

  • To delineate the effector mechanisms underlying myelin destruction in immune-mediated neuropathies.
  • To explore the roles of antibodies, complement system, and macrophages in demyelination.

Main Methods:

  • Review of existing research on effector mechanisms in immune-mediated neuropathies.
  • Analysis of antibody involvement, complement activation pathways (C3a, C5a, C3b, membrane attack complex), and Fc receptor-mediated macrophage targeting.
  • Examination of macrophage-derived molecules (oxygen radicals, nitric oxide, proteases, eicosanoids, cytokines like TNF-alpha and lymphotoxin) and their effects.

Related Experiment Videos

Main Results:

  • In GBS, antibodies to glycolipids, often linked to Campylobacter jejuni infection, are frequently detected.
  • Antibodies can trigger complement activation, leading to myelin damage and inflammation.
  • Antibodies can also recruit macrophages to myelin sheaths via Fc receptors.
  • Macrophages are key effector cells, releasing damaging molecules and cytokines (TNF-alpha, lymphotoxin) that cause demyelination and degeneration.
  • Evidence supports antibody-mediated complement activation in MAG-associated neuropathies.

Conclusions:

  • Antibody-mediated complement activation and macrophage-driven damage are critical effector mechanisms in immune-mediated neuropathies.
  • Understanding these pathways is crucial for developing targeted and effective treatments for demyelinating neuropathies.